仅一款疫苗获批,中慧生物再闯港交所

贝壳财经
Jul 28

江苏中慧元通生物科技股份有限公司(简称“中慧生物”)近日再次向港交所递交招股书。这是该公司继今年1月23日递表港交所失效后的再度冲刺,也是其第三次冲击上市。据悉,中慧生物已获中国证监会国际司境外发行上市备案通知书,拟发行不超过1.38亿股境外上市普通股。  “高端”疫苗战略承压  资料显示,中慧生物成立于2015年,致力于创新疫苗及采用新技术方法的传统疫苗的研发、制造及商业化,密切追踪传染病的全球...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10